CY1110563T1 - Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου - Google Patents

Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου

Info

Publication number
CY1110563T1
CY1110563T1 CY20091101263T CY091101263T CY1110563T1 CY 1110563 T1 CY1110563 T1 CY 1110563T1 CY 20091101263 T CY20091101263 T CY 20091101263T CY 091101263 T CY091101263 T CY 091101263T CY 1110563 T1 CY1110563 T1 CY 1110563T1
Authority
CY
Cyprus
Prior art keywords
derivative
neuropathic pain
relief
isoxazolic
acid
Prior art date
Application number
CY20091101263T
Other languages
English (en)
Inventor
Mauro Napoletano
Ermanno Moriggi
Original Assignee
Zambon S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon S.P.A. filed Critical Zambon S.P.A.
Publication of CY1110563T1 publication Critical patent/CY1110563T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με νέες φαρμακευτικές χρήσεις παραγώγου του ισοξαζολικού οξέος ή φαρμακευτικώς αποδεκτού άλατος του όσον αφορά την παρασκευή φαρμάκου που θα είναι χρήσιμο στην αγωγή νευροπαθητικού πόνου.
CY20091101263T 2004-11-16 2009-12-01 Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου CY1110563T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002187A ITMI20042187A1 (it) 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico
EP05815995A EP1817029B1 (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain

Publications (1)

Publication Number Publication Date
CY1110563T1 true CY1110563T1 (el) 2015-04-29

Family

ID=35840677

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091101263T CY1110563T1 (el) 2004-11-16 2009-12-01 Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου

Country Status (16)

Country Link
US (1) US7834040B2 (el)
EP (1) EP1817029B1 (el)
AT (1) ATE442848T1 (el)
CA (1) CA2586664C (el)
CY (1) CY1110563T1 (el)
DE (1) DE602005016711D1 (el)
DK (1) DK1817029T3 (el)
EA (1) EA013905B1 (el)
ES (1) ES2331921T3 (el)
HR (1) HRP20090592T1 (el)
IT (1) ITMI20042187A1 (el)
PL (1) PL1817029T3 (el)
PT (1) PT1817029E (el)
RS (1) RS51020B (el)
SI (1) SI1817029T1 (el)
WO (1) WO2006053860A1 (el)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985428A (en) * 1987-05-20 1991-01-15 Zambon Group S.P.A. Isoxazoles with nootropic activity

Also Published As

Publication number Publication date
ATE442848T1 (de) 2009-10-15
RS51020B (sr) 2010-10-31
US7834040B2 (en) 2010-11-16
EA013905B1 (ru) 2010-08-30
HRP20090592T1 (hr) 2009-12-31
CA2586664A1 (en) 2006-05-26
PL1817029T3 (pl) 2010-02-26
ITMI20042187A1 (it) 2005-02-16
DK1817029T3 (da) 2009-12-14
US20080108679A1 (en) 2008-05-08
SI1817029T1 (sl) 2010-01-29
DE602005016711D1 (de) 2009-10-29
WO2006053860A1 (en) 2006-05-26
ES2331921T3 (es) 2010-01-20
EP1817029A1 (en) 2007-08-15
EP1817029B1 (en) 2009-09-16
EA200701086A1 (ru) 2007-12-28
PT1817029E (pt) 2009-11-20
CA2586664C (en) 2012-09-18

Similar Documents

Publication Publication Date Title
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA201170249A1 (ru) 3,4-диарилпиразолы в качестве ингибиторов протеинкиназ
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MX2020008616A (es) Rocio de fentanilo sublingual.
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
NO20065271L (no) Sammensetninger innbefattende alfa-2-delta ligander
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
BRPI0817275A2 (pt) Combinação farmacêutica de alisquireno e valsartana
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
MX2012008509A (es) Agente terapeutico o profilactic para enfermedades del tracto biliar.
DK2244703T3 (da) Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier
CR10410A (es) Carboxamidas sustituidas.
GB2446341A (en) Method and system for transdermal drug delivery
GEP20125526B (en) Drug active in neuropathic pain
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
CY1110563T1 (el) Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου
DK2091520T3 (da) Oral doseringsform omfattende trisubstituerede glycerol-forbindelser
WO2006129056A3 (en) Process and novel salt
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen